November 11, 2010 (Atlanta, Georgia) — Modified-release (MR) prednisone is safe and more effective for morning symptoms of chronic rheumatoid arthritis (RA) than immediate-release prednisone or ...

DEERFIELD, Ill., July 26, 2012 /PRNewswire/ -- Horizon Pharma, Inc., (NASDAQ: HZNP) announced today that the U.S. Food and Drug Administration (FDA) has approved RAYOS ® (prednisone) delayed-release ...

The researchers found that participants in the MR group showed higher ACR20 response rates than did the placebo group (48% versus 29%, P<0.001). Patients in the MR group also displayed a greater ...

THE new adrenocortical steroid prednisone 1 was used in the treatment of 33 patients with rheumatoid arthritis. Among 33 patients with rheumatoid arthritis treated with prednisone, the disease was of ...

Share on Pinterest A new study looked at the effects of taking low dose steroids for people with rheumatoid arthritis. rudi suardi/Getty Images New research suggests that low doses of medications like ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Prednisone in doses of 20 to 39 mg for more than 1 month ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. To compare avacopan (CCX168, ChemoCentryx) with a ...

ATS 2025, San Francisco – Prednisone is recommended as the first-line treatment for pulmonary sarcoidosis, but this steroid causes a number of unwanted side effects. Now new research published at the ...

RAYOS approved for key rheumatology indications such as Rheumatoid Arthritis, Polymyalgia Rheumatica, Psoriatic Arthritis and Ankylosing Spondylitis. DEERFIELD, Ill., July 26, 2012 /PRNewswire/ -- ...